Luventix
Luventix is pioneering Intelligent Disease Diagnostics (IDD) using AI, ML, and deep learning to analyze urine samples for disease detection. Their proprietary technology creates a 'Digital Twin' of a patient's metabolic profile from a single urine sample, enabling faster, more affordable, and accessible screening for multiple medical conditions. The company's mechanistic AI modeling approach aims to significantly reduce research and development timelines compared to traditional methods. Luventix was founded in 2022 by Martin Martinov, Dejan Nenov, and George Holmes, inspired by the potential of AI to replicate biological detection capabilities.
Luventix
Luventix is pioneering Intelligent Disease Diagnostics (IDD) using AI, ML, and deep learning to analyze urine samples for disease detection. Their proprietary technology creates a 'Digital Twin' of a patient's metabolic profile from a single urine sample, enabling faster, more affordable, and accessible screening for multiple medical conditions. The company's mechanistic AI modeling approach aims to significantly reduce research and development timelines compared to traditional methods. Luventix was founded in 2022 by Martin Martinov, Dejan Nenov, and George Holmes, inspired by the potential of AI to replicate biological detection capabilities.